Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Étienne Buscail, Charlotte Maulat, Fabrice Muscari, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 852-852
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential
Aimi Syamima Abdul Manap, Faith Malambo Ngwenya, Meilarshny Kalai Selvan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
Keinosuke Ishido, Kenichi Hakamada, Norihisa Kimura, et al.
Annals of Gastroenterological Surgery (2020) Vol. 5, Iss. 1, pp. 7-23
Open Access | Times Cited: 27
Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study
Sarah Francini, Martha Duraes, Gauthier Rathat, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 428-428
Open Access | Times Cited: 8
A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer
Susanna W.L. de Geus, Teviah E. Sachs
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3427-3436
Closed Access | Times Cited: 8
Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
Talia Golan, Raffaella Casolino, Andrew V. Biankin, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 8
Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives
Gianluca Cassese, Ho‐Seong Han, Yoo‐Seok Yoon, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 6, pp. 911-924
Open Access | Times Cited: 7
Extracellular Vesicle-Dependent Cross-Talk in Cancer—Focus on Pancreatic Cancer
Lise Nannan, Jean‐Baptiste Oudart, Jean Claude Monboisse, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 19
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
Lily Nguyen, Daniela Schilling, Sophie Dobiasch, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3703-3703
Open Access | Times Cited: 18
KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence
Samuel Amintas, Benjamı́n Fernández, Alexandre Chauvet, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice
Xudong Zhao, Yongsu Ma, Xiu Rong Dong, et al.
HepatoBiliary Surgery and Nutrition (2021) Vol. 10, Iss. 6, pp. 796-810
Open Access | Times Cited: 15
Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer
Yixuan Zhang, Haochen Su, Haibo Wang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7649-7661
Open Access | Times Cited: 14
Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
Cheng Peng, Jiale Wang, Wenzhe Gao, et al.
International Journal of Medical Sciences (2020) Vol. 18, Iss. 3, pp. 660-671
Open Access | Times Cited: 14
Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGENTM): Early Clinical Results
Frédéric Ris, Minia Hellan, Jonathan Douissard, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4104-4104
Open Access | Times Cited: 12
Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers
Karolina Elżbieta Kaczor‐Urbanowicz, Jordan Cheng, Jonathan C. King, et al.
Pancreas (2020) Vol. 49, Iss. 9, pp. 1141-1152
Open Access | Times Cited: 12
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma
Alimu Dayimu, Lorena Di Lisio, Shubha Anand, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 9, pp. 1672-1680
Open Access | Times Cited: 4
Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities
Pedro Moutinho-Ribeiro, Inês A. Batista, Sofia Torres Quintas, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 31, pp. 4310-4327
Open Access | Times Cited: 6
Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
Sang Myung Woo, Min Kyeong Kim, Boram Park, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5466-5466
Open Access | Times Cited: 8
Electrochemical immunoplatform to help managing pancreatic cancer
Víctor Pérez‐Ginés, Rebeca M. Torrente‐Rodríguez, Marı́a Pedrero, et al.
Journal of Electroanalytical Chemistry (2023) Vol. 935, pp. 117312-117312
Open Access | Times Cited: 3
Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review)
Lu Xu, Yu Zhang, Guangfei Xie, et al.
Molecular Medicine Reports (2020)
Open Access | Times Cited: 8
Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma
Miquel Porta, José Pumarega, André F.S. Amaral, et al.
Environmental Research (2020) Vol. 190, pp. 109781-109781
Open Access | Times Cited: 7
Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
Nelson S. Yee
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2556-2556
Open Access | Times Cited: 7
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
Shelize Khakoo, Angelica Petrillo, Massimiliano Salati, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4396-4396
Open Access | Times Cited: 6
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence
Orimisan Samuel Adekolujo, Ahsan Wahab, Maxwell Akanbi, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Liquid biopsies in pancreatic cancer: targeting the portal vein
Christopher G. Chapman, Trevor Long, Irving Waxman
Journal of Pancreatology (2019) Vol. 2, Iss. 3, pp. 76-81
Open Access | Times Cited: 4
A loop‐shaped minimally invasive brush for improved cytology sampling of pancreatic cysts during EUS‐FNA
Filipe Marques, Francisco Baldaque‐Silva, Wouter van der Wijngaart, et al.
Medical Devices & Sensors (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 4

Scroll to top